Indian journal of Medical Biochemistry

Register      Login

VOLUME 20 , ISSUE 1 ( January-June, 2016 ) > List of Articles

RESEARCH ARTICLE

Cystatin C is a Better Marker of Renal Dysfunction in Hypertensive Pregnancies

Rajeev Ranjan, Anjana Singh

Citation Information : Ranjan R, Singh A. Cystatin C is a Better Marker of Renal Dysfunction in Hypertensive Pregnancies. Indian J Med Biochem 2016; 20 (1):21-27.

DOI: 10.5005/jp-journals-10054-0005

Published Online: 01-06-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Glomerular endotheliosis is an essential component in the pathophysiology of gestational hypertension (GH) and preeclampsia (PE) which results in renal dysfunction. This is not always detected by routine renal function tests, such as serum creatinine, urea, and uric acid. Cystatin C, an endogenous cysteine protease inhibitor, is completely absorbed by renal tubules and has been shown to be an ideal marker of glomerular filtration rate (GFR), which needs to be evaluated in assessing renal dysfunction occurring in GH and PE.

Aims

The present study is designed to evaluate serum cystatin C levels in normal pregnancy, GH, and PE and compare its efficacy with traditional renal function tests.

Materials and methods

In this prospective cross-sectional study, 75 subjects enrolled, comprised of 25 subjects each of normal pregnancy, GH, and PE. Serum cystatin C, blood urea, serum creatinine, serum uric acid, and urinary protein/creatinine ratio were estimated in all subjects prior to delivery.

Results

All renal parameters including cystatin C were significantly raised in GH and PE compared with control group. However, only serum cystatin C level (and no other renal parameters) was significantly higher in PE group compared with GH group. Area under the curve for cystatin C was maximum (0.917) compared with other parameters. Cystatin C had a higher sensitivity and specificity than other conventional markers.

Conclusion

Serum cystatin C is a better marker of renal dysfunction in hypertensive pregnancies.

How to cite this article

Singh A, Gupta M, Ranjan R, Saini V, Gupta SK. Cystatin C is a Better Marker of Renal Dysfunction in Hypertensive Pregnancies. Indian J Med Biochem 2016; 20(1):21-27.


PDF Share
  1. Renal physiology of pregnancy. Adv Chronic Kidney Dis 2013 May;20(3):209-214.
  2. The glomerular injury of preeclampsia. J Am Soc Nephrol 2007 Aug;18(8):2281-2284.
  3. False estimates of elevated creatinine. Perm J 2012 Spring;16(2):51-52.
  4. Serum cystatin C is a better marker for preeclampsia than serum creatinine or serum urate. Scand J Clin Lab Invest 2001;61(7):575-580.
  5. Reference intervals for serum cystatin C and factors influencing cystatin C levels other than renal function in the elderly. PLoS One 2014 Jan;9(1):e86066.
  6. Serum cystatin C as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol 2013 May;23(3):180-183.
  7. Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol 2011 Jan;22(1):147-155.
  8. Evaluation of renal function by cystatin C in renal transplant recipients. Exp Clin Transplant 2014 Feb;12(1):37-40.
  9. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes. Clin Lab 2013;59(11-12):1221-1229.
  10. Serum cystatin C and prediabetes in non-obese US adults. Eur J Epidemiol 2013 Apr;28(4):311-316.
  11. Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag 2011;7:467-474.
  12. Serum cystatin C with conventional renal tests: a study in patients with pre-eclampsia. Ann Pathol Lab Med 2014;1(2):A6-A9.
  13. Cystatin C in pre-eclampsia. J Matern Fetal Neonatal Med 2012 Jul;25(7):961-965.
  14. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002;62(2):141-147.
  15. Evaluation of cystatin C as a marker of estimated glomerular filtration rate (eGFR) in different stages of chronic kidney disease (CKD). Sch Acad J Biosci 2015;3(4):328-334.
  16. Evaluation of serum cystatin C compared with creatinine: a study in patients with pre-eclampsia. Int J Pharmacol Res 2015;5(11):273-275.
  17. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002 Aug;40(2):221-226.
  18. Renal markers in normal and hypertensive disorders of pregnancy in Indian women: a pilot study. Int J Reprod Contracept Obstet Gynecol 2013;2(4):514-520.
  19. Measurement of serum creatinine - current status and future goals. Clin Biochem Rev 2006 Nov;27(4):173-184.
  20. The application of serum cystatin C in estimating renal function in women with severe pre-eclamptic toxemia. Prog Obstet Ginecol 2015. Available from: http://dx.DOI.org/10.1016/j.pog.2015.06.005
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.